-

CRWV ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Coreweave, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Coreweave, Inc. (“Coreweave” or the “Company”) (NASDAQ:CRWV) securities during the period of March 28, 2025 through December 15, 2025, inclusive (“the Class Period”).

If you suffered a loss on your Coreweave investments, you have until March 13, 2026 to request lead plaintiff appointment in the lawsuit. For more information:

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is This Lawsuit About? The lawsuit alleges that (i) Coreweave had overstated its ability to meet customer demand for its service; (ii) the Company materially understated the scope and severity of the risk that Coreweave’s reliance on a single third party data center supplier presented for its ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on the Company’s revenues.

On October 30, 2025, Core Scientific announced it had not received enough shareholder votes to approve its merger agreement with Coreweave and, as a result, terminated the merger agreement. On the same date, Coreweave issued a press release concerning the Core Scientific shareholder votes stating: “Coreweave’s strategy remains unchanged. We will continue to execute with discipline against our roadmap to create long-term shareholder value including through opportunistic and strategic M&A.” On this news, the price of Coreweave shares declined by $7.39 per share, or approximately 5.5%, from $133.71 per share on October 31, 2025 to close at $126.32 on November 3, 2025.

On November 10, 2025, Coreweave issued a press release reporting its financial results for the third quarter of 2025. During the call, lowered guidance for 2025 were “affected by temporary delays related to a third-party data center developer.” On November 11, 2025, Individual Defendant Michael Intrator, Coreweave cofounder, gave an interview with CNBC and stated that “every single part of this quarter went exactly as we planned, except for one delay at a singular data center” before revising his statement to “a singular data center provider.” On this news, the price of Coreweave shares declined by $17.22 per share, or approximately 16.3%, from $105.61 per share on November 10, 2025 to close at $88.39 on November 10, 2025.

On December 15, 2025, The Wall Street Journal published an article entitled “Coreweave’s Staggering Fall from Market Grace Highlights AI Bubble Fears” reported that “the completion date” for the “[huge data-center cluster] has been pushed back several months.” On this news, the price of Coreweave shares declined by $6.24 per share, or approximately 7.9%, from $78.59 per share on December 12, 2025 to close at $72.35 on December 15, 2025.

[LEARN MORE ABOUT THE LAWSUIT]

The Lead Plaintiff Appointment Process. The federal securities laws permit any investor who acquired eligible securities during the class period to seek appointment as lead plaintiff in a class action lawsuit. Courts typically appoint the investor(s) with the largest financial loss in the case and the ability to represent the class rather than investors with simply the largest investment portfolio. Courts regularly appoint individual investors, whether acting alone or as a group, as lead plaintiffs. The rights of any investor who bought shares during the class period are generally already protected. However, lead plaintiffs have the power to influence case strategy and have a say in settlement decisions, as well as decisions concerning allocation of settlement funds among class members.

[LEARN MORE ABOUT THE LEAD PLAINTIFF PROCESS]

What Should I Do? If you purchased or otherwise acquired Coreweave securities, have information, or would like to learn more about this lawsuit m , please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:CRWV

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

FFIV INVESTOR ALERT: Kirby McInerney LLP Reminds F5, Inc. Investors of Important Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your F5, Inc. (“F5” or the “Company”) (NASDAQ:FFIV) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until February 17, 2026 to ask the Court to appoint them as lead plaintiff. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is The Lawsuit About? The...

Navan, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (NAVN)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Navan, Inc. (“Navan” or the “Company”) (NASDAQ:NAVN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On October 30, 2025, Navan conducted its initial public offering, selling approximately 36.9 million shares at...

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 15, 2025, Scorpion Capital published a report that described Soleno’s only product, Vykat XR, as ov...
Back to Newsroom